- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.11. | Is Martin Makary Trump's pick for FDA Commissioner? | ||
| 22.11. | FDA experts lukewarm on AZ's anticoagulant antidote Andexxa | ||
| 22.11. | Jazz gets first FDA nod for HER2 bispecific Ziihera | ||
| 21.11. | Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn | ||
| 21.11. | Novartis raises mid-term sales outlook on pipeline promise | ||
| 21.11. | Eisai debuts biliary tract cancer drug in Japan | ||
| 21.11. | 23andMe stock sell-off adds to its woes | ||
| 21.11. | Pfizer elevates Chris Boshoff to top R&D role | ||
| 20.11. | Sage wilts as Huntington's prospect flunks trial | ||
| 20.11. | Pfizer bags EU okay for haemophilia drug Hympavzi | ||
| 20.11. | Trump picks celebrity doc Mehmet Oz to lead Medicare | ||
| 20.11. | NICE blames companies for breakdown in Enhertu talks | ||
| 20.11. | MSD says subcutaneous Keytruda matches IV form | ||
| 19.11. | NIH algorithm matches patients to clinical trials | ||
| 19.11. | GSK drug raises hopes for patients with PBC itch | ||
| 19.11. | J&J plots filings after psoriasis drug clears phase 3 test | ||
| 19.11. | FDA says no to Astellas' geographic atrophy drug | ||
| 19.11. | Grifols linked to €7bn takeover offer from Brookfield | ||
| 18.11. | Neurogene falls again on Rett gene therapy side effects | ||
| 18.11. | AI could 'cut ECG result wait times and speed up treatment' | ||
| 18.11. | AbbVie bags EU nod for key drug from ImmunoGen takeover | ||
| 18.11. | Tirzepatide gets a big win in obesity-related heart failure | ||
| 18.11. | Syndax gets FDA okay for first-in-class leukaemia drug | ||
| 15.11. | Trump pick of RFK for top US health job astounds critics | ||
| 14.11. | MSD joins PD-1/VEGF push in cancer with LaNova deal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
